First news on Jarred Younger's work to do some fast-tracking!!!! I'll definitely have a blog on this at some point.
Younger is in the early stages of creating a “fast-track clinical trial center.” That’s a working title, of course; it’ll probably end up with some wealthy donor’s name in front of it.
[fright]
[/fright]Or at least that’s Younger’s hope. He’s looking to raise up to $4 million over the next couple of years to make his fast-track center a reality.\
As envisioned, the center would test out multiple treatments for fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) simultaneously. It would rely on the support of donors, cutting through the NIH’s red tape and long waits for funding. On average, it takes about eight to 10 years for a treatment to navigate through the NIH’s grant system before it’s ready for public use.
Younger’s center would cut that time to about three years.
“I am not critical of NIH for how they distribute funds,” he explained. “Given their limited budget, they have to be cautious to make sure they don’t throw large amounts of money at ideas that don’t work. The NIH process is good for science in general, but it isn’t designed to support clinical trials. So, the fast-track center is a supplemental, but needed research entity.”
Younger is in the early stages of creating a “fast-track clinical trial center.” That’s a working title, of course; it’ll probably end up with some wealthy donor’s name in front of it.
[fright]
As envisioned, the center would test out multiple treatments for fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) simultaneously. It would rely on the support of donors, cutting through the NIH’s red tape and long waits for funding. On average, it takes about eight to 10 years for a treatment to navigate through the NIH’s grant system before it’s ready for public use.
Younger’s center would cut that time to about three years.
“I am not critical of NIH for how they distribute funds,” he explained. “Given their limited budget, they have to be cautious to make sure they don’t throw large amounts of money at ideas that don’t work. The NIH process is good for science in general, but it isn’t designed to support clinical trials. So, the fast-track center is a supplemental, but needed research entity.”
![ME/CFS lecture | Dr Nancy Klimas | 2011 [Chronic Fatigue Syndrome / SEID / New Zealand] - YouTube](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
